Director Frederick W. Gluck to retire from CytomX board effective June 30, 2022

CytomX Therapeutics, Inc.

Frederick W. Gluck to retire from CytomX board effective June 30, 2022.
Retirement not due to any dispute or disagreement with the company.
No replacement named; board will be reduced by one member.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Frederick W. Gluck

director

CTMX · CytomX Therapeutics, Inc.

Effective: 2022-06-30
Filed: March 23, 2022, 7:59 PM ET

On March 23, 2022, CytomX Therapeutics, Inc. (the “Company”) announced the retirement of Frederick W. Gluck from the Company’s board of directors, effective as of June 30, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Frederick W. Gluck retired as director at CytomX Therapeutics, Inc..

Action: retired
Role: director

Exact text from the filing

On March 23, 2022, CytomX Therapeutics, Inc. (the “Company”) announced the retirement of Frederick W. Gluck from the Company’s board of directors, effective as of June 30, 2022.

View on SEC.gov

CytomX Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-082793

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.